Lv3
400 积分 2025-07-29 加入
Tocilizumab for severe and refractory mucous membrane pemphigoid
7天前
已完结
Linagliptin is a risk factor for bullous pemphigoid associated with BP180-NC16A/BP230 seronegativity and milder severity: evidence from a prospective case-control study supporting ECD-BP180 ELISA in reducing diagnostic delay
11天前
已完结
False negative rate of direct immunofluorescence in bullous pemphigoid does not significantly differ by anatomic site
18天前
已完结
Patient phenotyping to guide therapeutic strategies in bullous pemphigoid: towards personalized medicine in autoimmune bullous diseases
18天前
已完结
Stapokibart’s clinical effectiveness in treating moderate-to-severe bullous pemphigoid in the elderly
18天前
已完结
Real-World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens
24天前
已完结
Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence
24天前
已完结
HLA genotype, clinical and immunofluorescence findings of 30 patients with type VII collagen antibody positive subepidermal bullous disease
24天前
已完结
The Secretome of Bullous Pemphigoid IgG‐Treated Keratinocytes Induces a Pro‐Inflammatory Eosinophil Response
24天前
已完结
Treg cells as potential therapeutic targets for bullous pemphigoid: A review
24天前
已关闭
皖公网安备34019202002308
